Journal article
Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia
- Abstract:
- Mutation or epigenetic silencing of the transcription factor C/EBPα is observed in ~10% of patients with acute myeloid leukemia (AML). In both cases, a common global gene expression profile is observed, but downstream targets relevant for leukemogenesis are not known. Here, we identify Sox4 as a direct target of C/EBPα whereby its expression is inversely correlated with C/EBPα activity. Downregulation of Sox4 abrogated increased self-renewal of leukemic cells and restored their differentiation. Gene expression profiles of leukemia-initiating cells (LICs) from both Sox4 overexpression and murine C/EBPα mutant AML models clustered together but differed from other types of AML. Our data demonstrate that Sox4 overexpression resulting from C/EBPα inactivation contributes to the development of leukemia with a distinct LIC phenotype. © 2013 Elsevier Inc.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 3.1MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.ccr.2013.09.018
Authors
- Publisher:
- Cell Press
- Journal:
- Cancer Cell More from this journal
- Volume:
- 24
- Issue:
- 5
- Pages:
- 575-588
- Publication date:
- 2013-01-01
- DOI:
- EISSN:
-
1878-3686
- ISSN:
-
1535-6108
- UUID:
-
uuid:05e65212-c680-4e57-b607-86d88fabf815
- Local pid:
-
pubs:440202
- Source identifiers:
-
440202
- Deposit date:
-
2013-12-12
Terms of use
- Copyright holder:
- Elsevier Inc
- Copyright date:
- 2013
- Notes:
- Copyright © 2013 Elsevier Inc. Under an Elsevier user license.
- Licence:
- Other
If you are the owner of this record, you can report an update to it here: Report update to this record